Studies of the mode of action of antitumour triazenes and triazines—II. Investigation of the selective toxicity of 1-aryl-3,3-dimethyltriazenes
- 1 January 1981
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 30 (1), 89-93
- https://doi.org/10.1016/0006-2952(81)90288-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Antitumour activity, biomimetic oxidation and metabolism of heteroalicyclic triazenesBiochemical Pharmacology, 1979
- Microsomal mediated metabolism of dialkylaryltriazenesZeitschrift für Krebsforschung und Klinische Onkologie, 1979
- α-hydroxylated derivatives of antitumour dimethyltriazenesTetrahedron Letters, 1978
- Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 2. On the role of correlation analysis in decision making in drug modification. Toxicity quantitative structure-activity relationships of 1-(X-phenyl)-3,3-dialkyltriazenes in miceJournal of Medicinal Chemistry, 1978
- MonoalkyltriazenesChemical Society Reviews, 1978
- Tumour inhibitory triazenes: Structural requirements for an active metaboliteBiochemical Pharmacology, 1976
- Unterschiedliche carcinogene Wirkungen von 1-Phenyl- und 1-(Pyridyl-3)-3,3-diäthyl-triazen an BD-Ratten nach Gabe einer Einzeldosis am 1., 10. oder 30. LebenstagZeitschrift für Krebsforschung und Klinische Onkologie, 1976
- Studies on the mechanism of action of the tumour inhibitory triazenesBiochemical Pharmacology, 1973
- 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)—A new antitumor agent with activity against malignant melanomaEuropean Journal of Cancer (1965), 1972
- Mechanism of carcinogenesis with 1-Aryl-3,3-dialkyltriazenes. Enzymatic dealkylation by rat liver microsomal fraction in vitroBiochemical Pharmacology, 1969